News
-
Finding rare disease treatments: 2 patient leaders share their stories
Listen to two of our Rare As One partners sharing their stories and experiences navigating diagnosis and organizing their communities to accelerate research.
-
Mark Zuckerberg’s charity is giving $250 million to Chicago’s up and coming biotech sector after it beat out 36 other cities: ‘We competed and won’
-
Does shingles vaccination cut dementia risk? Large study hints at a link
Analysis of nearly 300,000 people finds an association between the shingles jab and a lower rate of dementia — but questions linger.
-
Learning to ‘speak amino acid’: How language models can change our approach to medicine
Biohub-affiliated researchers are using the technology behind AI chatbots to unlock codes in human biology.
-
High Risk, High Reward: Shana Kelley on Building a New Biohub
President of new CZ Biohub Chicago brings experience in startups, nanotech, chemistry, and more
-
Accelerating open science in Latin America
At a recent workshop in Buenos Aires, Argentina, researchers from around the world came together to accelerate computational biomedicine and open science in Latin America.
-
Cómo acelerar la ciencia abierta en América Latina
-
Gustavo B. Menezes’ mission to increase access to bioimaging equipment with labs around the world
Meet a Brazilian biologist who revolutionized imaging science in his country and helped other scientists gain the tools to explore the secrets of life at a microscopic level.
-
Renowned Scientists Honored at 9th Annual Breakthrough Prize Ceremony in Los Angeles
The Breakthrough Prize celebrates scientific achievements in physics, life sciences, and mathematics.
-
The Economist: Worlds Within, Worlds Without
Geoffrey Carr of The Economist covers CZI and CZ Biohub SF’s efforts to support the Human Cell Atlas
-
Cracking the Puzzle of Lower Respiratory Tract Infections in Children
CZ Biohub SF researchers and colleagues leverage genomics and machine learning to better diagnose LRTI, a major killer of children worldwide
-
An Age-Old Battle: Scientists Uncover What Makes Malaria Such a Wily Foe
A new study by researchers at CZ Biohub SF and UCSF points the way to a better vaccine design